Inscripta is developing the world’s first benchtop platform for scalable digital genome engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of s... Read more
Genesis Therapeutics
5 followers
Eikon Therapeutics
4 followers
Korro Bio
3 followers
Scribe Therapeutics
2 followers
Kura Oncology
22 followers
REVOLUTION Medicines
19 followers
KIPP Schools
13 followers
Halozyme Therapeutics
10 followers
Affinia Therapeutics
1 follower
BillionToOne
8 followers
Summit Therapeutics
8 followers
Inari
7 followers